616 related articles for article (PubMed ID: 34407392)
1. Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer.
Goc J; Lv M; Bessman NJ; Flamar AL; Sahota S; Suzuki H; Teng F; Putzel GG; ; Eberl G; Withers DR; Arthur JC; Shah MA; Sonnenberg GF
Cell; 2021 Sep; 184(19):5015-5030.e16. PubMed ID: 34407392
[TBL] [Abstract][Full Text] [Related]
2. ILC3s select microbiota-specific regulatory T cells to establish tolerance in the gut.
Lyu M; Suzuki H; Kang L; Gaspal F; Zhou W; Goc J; Zhou L; Zhou J; Zhang W; ; Shen Z; Fox JG; Sockolow RE; Laufer TM; Fan Y; Eberl G; Withers DR; Sonnenberg GF
Nature; 2022 Oct; 610(7933):744-751. PubMed ID: 36071169
[TBL] [Abstract][Full Text] [Related]
3. Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4⁺ T cells.
Hepworth MR; Fung TC; Masur SH; Kelsen JR; McConnell FM; Dubrot J; Withers DR; Hugues S; Farrar MA; Reith W; Eberl G; Baldassano RN; Laufer TM; Elson CO; Sonnenberg GF
Science; 2015 May; 348(6238):1031-5. PubMed ID: 25908663
[TBL] [Abstract][Full Text] [Related]
4. CTLA-4-expressing ILC3s restrain interleukin-23-mediated inflammation.
Ahmed A; Joseph AM; Zhou J; Horn V; Uddin J; Lyu M; Goc J; ; Sockolow RE; Wing JB; Vivier E; Sakaguchi S; Sonnenberg GF
Nature; 2024 Jun; 630(8018):976-983. PubMed ID: 38867048
[TBL] [Abstract][Full Text] [Related]
5. Microbiota-induced tissue signals regulate ILC3-mediated antigen presentation.
Lehmann FM; von Burg N; Ivanek R; Teufel C; Horvath E; Peter A; Turchinovich G; Staehli D; Eichlisberger T; Gomez de Agüero M; Coto-Llerena M; Prchal-Murphy M; Sexl V; Bentires-Alj M; Mueller C; Finke D
Nat Commun; 2020 Apr; 11(1):1794. PubMed ID: 32286285
[TBL] [Abstract][Full Text] [Related]
6. CD1d-Dependent iNKT Cells Control DSS-Induced Colitis in a Mouse Model of IFNγ-Mediated Hyperinflammation by Increasing IL22-Secreting ILC3 Cells.
Park HJ; Lee SW; Van Kaer L; Hong S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513946
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between ILC3s and Microbiota: Implications for Colon Cancer Development and Treatment with Immune Check Point Inhibitors.
Drommi F; Calabrò A; Vento G; Pezzino G; Cavaliere R; Omero F; Muscolino P; Granata B; D'Anna F; Silvestris N; De Pasquale C; Ferlazzo G; Campana S
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296855
[TBL] [Abstract][Full Text] [Related]
8. IL-21 Controls ILC3 Cytokine Production and Promotes a Protective Phenotype in a Mouse Model of Colitis.
Poholek CH; Dulson SJ; Zajac AJ; Harrington LE
Immunohorizons; 2019 Jun; 3(6):194-202. PubMed ID: 31356165
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Regulation of Group 3 Innate Lymphoid Cells and Their Role in Inflammatory Bowel Disease.
Song D; Lai L; Ran Z
Front Immunol; 2020; 11():580467. PubMed ID: 33193381
[TBL] [Abstract][Full Text] [Related]
10. Controversial role of ILC3s in intestinal diseases: A novelty perspective on immunotherapy.
Zhang Y; Feng X; Chen J; Liu J; Wu J; Tan H; Mi Z; Rong P
Front Immunol; 2023; 14():1134636. PubMed ID: 37063879
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation.
Powell N; Lo JW; Biancheri P; Vossenkämper A; Pantazi E; Walker AW; Stolarczyk E; Ammoscato F; Goldberg R; Scott P; Canavan JB; Perucha E; Garrido-Mesa N; Irving PM; Sanderson JD; Hayee B; Howard JK; Parkhill J; MacDonald TT; Lord GM
Gastroenterology; 2015 Aug; 149(2):456-67.e15. PubMed ID: 25917784
[TBL] [Abstract][Full Text] [Related]
12. ZBTB46 defines and regulates ILC3s that protect the intestine.
Zhou W; Zhou L; Zhou J; ; Chu C; Zhang C; Sockolow RE; Eberl G; Sonnenberg GF
Nature; 2022 Sep; 609(7925):159-165. PubMed ID: 35831503
[TBL] [Abstract][Full Text] [Related]
13. ILC3s control airway inflammation by limiting T cell responses to allergens and microbes.
Teng F; Tachó-Piñot R; Sung B; Farber DL; Worgall S; Hammad H; Lambrecht BN; Hepworth MR; Sonnenberg GF
Cell Rep; 2021 Nov; 37(8):110051. PubMed ID: 34818549
[TBL] [Abstract][Full Text] [Related]
14. Group 3 innate lymphoid cells: A trained Gutkeeper.
Serafini N; Di Santo JP
Immunol Rev; 2024 May; 323(1):126-137. PubMed ID: 38491842
[TBL] [Abstract][Full Text] [Related]
15. Group 3 innate lymphoid cells produce the growth factor HB-EGF to protect the intestine from TNF-mediated inflammation.
Zhou L; Zhou W; Joseph AM; Chu C; Putzel GG; Fang B; Teng F; Lyu M; Yano H; Andreasson KI; Mekada E; Eberl G; Sonnenberg GF
Nat Immunol; 2022 Feb; 23(2):251-261. PubMed ID: 35102343
[TBL] [Abstract][Full Text] [Related]
16. Activation of DR3 signaling causes loss of ILC3s and exacerbates intestinal inflammation.
Li J; Shi W; Sun H; Ji Y; Chen Y; Guo X; Sheng H; Shu J; Zhou L; Cai T; Qiu J
Nat Commun; 2019 Jul; 10(1):3371. PubMed ID: 31358760
[TBL] [Abstract][Full Text] [Related]
17. Group 3 innate lymphoid cells require BATF to regulate gut homeostasis in mice.
Wu X; Khatun A; Kasmani MY; Chen Y; Zheng S; Atkinson S; Nguyen C; Burns R; Taparowsky EJ; Salzman NH; Hand TW; Cui W
J Exp Med; 2022 Nov; 219(11):. PubMed ID: 36048018
[TBL] [Abstract][Full Text] [Related]
18. Differential Effects of the Absence of Nkx2-3 and MAdCAM-1 on the Distribution of Intestinal Type 3 Innate Lymphoid Cells and Postnatal SILT Formation in Mice.
Vojkovics D; Kellermayer Z; Gábris F; Schippers A; Wagner N; Berta G; Farkas K; Balogh P
Front Immunol; 2019; 10():366. PubMed ID: 30891037
[TBL] [Abstract][Full Text] [Related]
19. Adoptive Transfer of Group 3-Like Innate Lymphoid Cells Restores Mouse Colon Resistance to Colonization of a Gamma Interferon-Susceptible Chlamydia muridarum Mutant.
He Y; Xu H; Song C; Koprivsek JJ; Arulanandam B; Yang H; Tao L; Zhong G
Infect Immun; 2021 Jan; 89(2):. PubMed ID: 33139384
[TBL] [Abstract][Full Text] [Related]
20. Composite Sophora Colon-Soluble Capsule Ameliorates DSS-Induced Ulcerative Colitis in Mice via Gut Microbiota-Derived Butyric Acid and NCR
Chen MJ; Feng Y; Gao L; Lin MX; Wang SD; Tong ZQ
Chin J Integr Med; 2023 May; 29(5):424-433. PubMed ID: 35412217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
